Pharma BD Deal Intelligence
Bristol-Myers Squibb Company / DuPont Pharmaceuticals Company
2001 · Acquisition/Merger · $7.8B · Complete
Announcement Sentiment
75
Strongly positive
Announced 2001-06-07; closed 2001-10-01. BMS acquired DuPont's pharma unit; key assets Sustiva (efavirenz, HIV NNRTI), Coumadin, Cardiolite. Source: SEC 8-K, BMS press release.
Key facts
- Announced Jun 07, 2001
- Closed Oct 01, 2001
- Deal value $7.8B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals